TCF21 and breast cancer: The highly significant enrichment of breast cancer variants in the bQTL category is consistent with TCF21 being a known tumor suppressor and that is dysregulated in breast cancer, but the enrichment of breast cancer variants among the caQTLs and clQTLs is surprising and suggests a similar genomic and genetic architecture between HCASMC and breast cancer risk genes [23].